Daniel Norwood, PhD Boehringer Ingelheim Pharmaceuticals, Inc.

Dr. Norwood is Distinguished Research Fellow in Analytical Development for Boehringer Ingelheim Pharmaceuticals and leads their Structural Analysis Section. He received his PhD from the University of North Carolina at Chapel Hill and has held senior pharmaceutical industry positions at Magellan Laboratories, Inc. and the Glaxo Research Institute. He was Medical Research Assistant Professor at Duke University Medical Center and has held an appointment as Adjunct Assistant Professor at the University of North Carolina. He chaired the PQRI (Product Quality Research Institute) Working Group on Leachables and Extractables, and is currently a member of the PQRI Working Group on Leachables and Extractables in Parenteral and Ophthalmic Drug Products. He was a founding member on the Board of Directors of ELSIE (The Extractables Leachables Safety Information Exchange), and serves on the Governing Board of the Eastern Analytical Symposium. He also serves on the USP Packaging, Storage and Distribution Expert Committee and chairs their subcommittee on extractables and leachables. Dr. Norwood received the Glaxo CEO's Award in 1994, the Boehringer Ingelheim President's Award in 2007, the PQRI Excellence in Research Award in 2009, and was a co-recipient of the USP Award for an Innovative Response to Public Health Challenges in 2013.